|
1
|
Zhang Q, Hou L, Liu L, Li H, Chang J and
Feng L: Medication rule of modern traditional chinese medicine
compound prescriptions for the treatment of cancer-induced bone
pain based on data mining. World Chinese Medicine. 18:2815–2819.
2023.
|
|
2
|
Coleman RE: Clinical features of
metastatic bone disease and risk of skeletal morbidity. Clin Cancer
Res. 12:6243S–6249S. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mercadante S and Fulfaro F: World Health
Organization guidelines for cancer pain: A reappraisal. Ann Oncol.
16 (Suppl 4):iv132–iv135. 2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chang JY: A preclinical study of bone pain
patch for the treatment of bone metastases in prostate cancer.
Peking Union Medical College, 2024.
|
|
5
|
Min QM, Liu C and Liu L: Traditional
Chinese emotional nursing alleviates cancer pain in cancer
patients: A Meta analysis. Chinese Evidence-based Nursing.
10:2118–2122. 2024.
|
|
6
|
Wan Y, Deng H, Xia Y, Wen X and Yang G:
Qualitative study on perioperative experience of intrathecal
morphine pump implantation in patients with cancer pain. Journal of
Modern Medicine and Health. 41:113–116. 2025.
|
|
7
|
Chen X, Zheng L, Zhan L, Ye K, Wang J and
Gou B: Comparative study on the analgesic effect of
ultrasound-guided quadratus lumborum block combined with oxycodone
in different approaches after laparoscopic colorectal-carcinoma
surgery. Progress in Modern Biomedicine. 24:3061–3065. 2024.
|
|
8
|
Xu Y: Efficacy and safety of oxycodone
hydrochloride extended-release tablets in analgesia in patients
with intermediate and advanced malignant tumors. Chinese Journal of
Clinical Rational Drug Use. 18:109–112. 2025.
|
|
9
|
Yunbo B, Zhigang F and Jin J: Clinical
observation of oxycodone hydrochloride sustained-release tablets on
neuropathic pain in patients with primary lung cancer during
radiotherapy and chemotherapy. China Medicine. 20:47–52. 2025.
|
|
10
|
Wang XM, Li W, Li M, Shang TZ, Yu ZQ and
Zhang CL: Investigation on the Chinese medical staff for the
clinical application and cognitive status of transdermal fentanyl
patch in the treatment of cancer pain. Herald of Medicine.
42:1248–1254. 2023.
|
|
11
|
Swarm RA, Paice JA, Anghelescu DL, Are M,
Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, et
al: Adult cancer pain, version 3.2019, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 17:977–1007.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yang J, Wahner-Roedler DL, Zhou X, Johnson
LA, Do A, Pachman DR, Chon TY, Salinas M, Millstine D and Bauer BA:
Acupuncture for palliative cancer pain management: Systematic
review. BMJ Support Palliat Care. 11:264–270. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Russo M, Graham B and Santarelli DM:
Gabapentin-friend or foe? Pain Pract. 23:63–69. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chang CY, Challa CK, Shah J and Eloy JD:
Gabapentin in acute postoperative pain management. Biomed Res Int.
2014(631756)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xu JY: Evaluation of analgesic effects of
the combination of gabapentin or duloxetine with resveratrol.
Jiangsu Ocean University, 2022.
|
|
16
|
Biggs JE, Stemkowski PL, Knaus EE,
Chowdhury MA, Ballanyi K and Smith PA: Suppression of network
activity in dorsal horn by gabapentin permeation of TRPV1 channels:
Implications for drug access to cytoplasmic targets. Neurosci Lett.
584:397–402. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hägg S, Jönsson AK and Ahlner J: Current
evidence on abuse and misuse of gabapentinoids. Drug Saf.
43:1235–1254. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
He YY, Chen ZH, Zhao L and Fan XG:
Clinical efficacy of gabapentin combined with amitriptyline in
patients with opioid tolerance and severe cancer pain: A
retrospective study. Journal of Third Military Medical University.
39:1939–1943. 2017.
|
|
19
|
Wu YC: Clinical study of gabapentin in
combination with opioids in cancer pain. Guangxi Medical
University, 2009.
|
|
20
|
Li XM, Liu DQ, Wu HY, Yang C and Yang L:
Controlled-release oxycodone alone or combined with gabapentin for
management of malignant neuropathic pain. Chin J Cancer Res.
22:80–86. 2010.
|
|
21
|
Caraceni A, Zecca E, Bonezzi C, Arcuri E,
Tur RY, Maltoni M, Visentin M, Gorni G, Martini C, Tirelli W, et
al: Gabapentin for neuropathic cancer pain: A randomized controlled
trial from the gabapentin cancer pain study group. J Clin Oncol.
22:2909–2917. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Keskinbora K, Pekel AF and Aydinli I:
Gabapentin and an opioid combination versus opioid alone for the
management of neuropathic cancer pain: A randomized open trial. J
Pain Symptom Manage. 34:183–189. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ross JR, Goller K, Hardy J, Riley J,
Broadley K, A'Hern R and Williams J: Gabapentin is effective in the
treatment of cancer-related neuropathic pain: A prospective,
open-label study. J Palliat Med. 8:1118–1126. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sterne JAC, Savović J, Page MJ, Elbers RG,
Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge
SM, et al: RoB 2: A revised tool for assessing risk of bias in
randomised trials. BMJ. 366(l4898)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wells GA, Shea B, O'Connell D, Peterson J,
Welch V, Losos M, et al: The Newcastle-Ottawa Scale (NOS) for
assessing the quality of nonrandomised studies in meta-analyses.
Ottawa Hospital Research Institute, 2010.
|
|
26
|
Balduzzi S, Rücker G and Schwarzer G: How
to perform a meta-analysis with R: A practical tutorial. Evid Based
Ment Health. 22:153–160. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Viechtbauer W and Cheung MW: Outlier and
influence diagnostics for meta-analysis. Res Synth Methods.
1:112–125. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Zhao J: Clinical observation of morphine
combined with gabapentin in the treatment of moderate and severe
neuropathic cancer pain. China Practical Medicine. 11:105–107.
2016.
|
|
29
|
Zhao XH and Xia J: Efficacy of fentanyl
patch combined with gabapentin in the treatment of cancer pain in
pancreatic cancer. Strait Pharm J. 32:150–152. 2020.
|
|
30
|
Jiang W, Song H and Wang E: Analysis of
the clinical effect of oxycodone hydrochloride extended-release
tablets combined with gabapentin in the treatment of moderate to
severe cancer pain. J Med Theory Pract. 34:438–440. 2021.
|
|
31
|
Sun L: Clinical Analysis of Gabapentin
Combined with Morphine Sulfate Sustained-release Tablets in the
Treatment of Cancerous Neuropathic Pain. China Foreign Medical
Treatment. 40:101–103. 2021.
|
|
32
|
Teng L, Dai J, Shao H, Zhao L, Lin S,
Zhang W and Zou H: Gabapentin enhances the antinociceptive effect
of intrathecal morphine in refractory cancer pain patients. Support
Care Cancer. 29:7611–7616. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Su L: Clinical observation and care of
fentanyl patch combined with gabapentin in the treatment of bone
metastasis cancer pain. China Medical Engineering. 21:90–92.
2013.
|
|
34
|
Liu XC, Ding ZP and Zhou XF: Effects of
gabapentin combined with morphine sulfate sustained release tablets
on pain of middle-late stage cancer patients after chemotherapy and
radiotherapy. The Practical Journal of Cancer. (11):1504–1506.
2014.
|
|
35
|
Qin XB, Song CJ, Yu T, Li JY, Liu TF and
Chen XM: Efficacy observation of oxycodone hydrochloride
controlled-release tablets combined with gabapentin for the
treatment of malignant neuropathic pain. ACTA Academiae Medicinae
Xuzhou. (9):594–597. 2015.
|
|
36
|
Chen L, Shen W, Han X, Yuan Y, Liang D,
Yin Q, et al: Clinical observation of sustained-release morphine
sulphate combined with gabapentin in the treatment of cancer pain.
Chinese Journal of Pain Medicine. 21:679–683. 2015.
|
|
37
|
Zhang N: Effect and adverse reactions of
gabapentin combined with morphine sulfate controlled-release
tablets in the treatment of carcinoneuralgia. Chinese Journal of
Practical Nervous Diseases. 19:40–42. 2016.
|
|
38
|
Zhang LJ, et al: Analysis of the efficacy
of gabapentin combined with morphine hydrochloride extended-release
tablets in the treatment of patients with severe cancer pain. China
Health Care and Nutrition. 26:174–175. 2016.
|
|
39
|
Chen ZH, et al: Clinical observation of
oxycodone hydrochloride extended-release tablets combined with
gabapentin capsules in the treatment of cancer pain. Guangdong
Medical Journal. 38:136–138. 2017.
|
|
40
|
Jiang B: Clinical study of opioids in
combination with gabapentin in cancer pain. Qinghai University,
2017.
|
|
41
|
She XH and Jiang LY: A study on the effect
of gabapentin and morphine hydrochloride sustained-release tablets
in relieving pain in patients with cancer pain. Chinese Remedies
and Clinics. 17:1824–1826. 2017.
|
|
42
|
Yan HM, et al: Clinical observation of
gabapentin combined with morphine sulfate extended-release tablets
in the treatment of cancerous neuropathic pain. Zhejiang Clinical
Medical Journal. 20:1073–1075. 2018.
|
|
43
|
Ru AZ, et al: Analysis of the effect of
gabapentin combined with oxycodone hydrochloride in the treatment
of cancerous neuropathic pain. Health Vocational Education.
36:84–86. 2018.
|
|
44
|
Fu XZ: Effect of the combination of
morphine sulfate extended-release tablets and gabapentin capsules
in the treatment of cancer pain and its effect on quality of life.
Journal of North Pharmacy. 15:104–105. 2018.
|
|
45
|
Yan QY: Clinical study of opioids combined
with gabapentin in the treatment of cancer pain and analysis of
real-world cancer pain diagnosis and treatment. Hebei Medical
University, 2018.
|
|
46
|
Zhou H, Zhang H, Qian X and Ge W: Efficacy
and safety of gabapentin adjuvant therapy for neuropathic cancer
pain. China Pharmacist. 22:1278–1286. 2019.
|
|
47
|
Meng J: Effect of gabapentin combined with
oxycodone hydrochloride on patients with advanced cancer-induced
pain and its effect on pain media. Medical Information. 32:146–147.
2019.
|
|
48
|
Zhu RH: Clinical analysis of gabapentin
combined with morphine sulfate extended-release tablets in the
treatment of cancerous neuropathic pain. Health Guide.
(48)(100)2020.
|
|
49
|
Zhang X: Analysis of the effect of
gabapentin combined with oxycodone hydrochloride extended-release
tablets in the treatment of cancerous neuropathic pain.
Contemporary Medicine Forum. 19(23)2021.
|
|
50
|
Jiang W, Wang L, Wu T, Xiu X, Yang X and
Zhang S: Clinical efficacy of oxycontin combined with gabapentin on
neuropathic cancer pain and its effect on immune function. Int J
Clin Exp Med. 14:246–254. 2021.
|
|
51
|
Qi N: Observation of the efficacy of
gabapentin combined with oxycodone hydrochloride extended-release
tablets in the treatment of cancerous neuropathic pain. Health
Guide. (20):7–9. 2024.
|
|
52
|
Wu X, Li N, Zhu J, Wu Y, Du Y, et al:
Observation of opioid combined with corticosteroids or
anticonvulsants for advanced cancer patients with pain. Chinese
Clinical Oncology. 16:58–60. 2011.
|
|
53
|
Shinde S, Gordon P, Sharma P, Gross J and
Davis MP: Use of non-opioid analgesics as adjuvants to opioid
analgesia for cancer pain management in an inpatient palliative
unit: Does this improve pain control and reduce opioid
requirements? Support Care Cancer. 23:695–703. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Eckhardt K, Ammon S, Hofmann U, Riebe A,
Gugeler N and Mikus G: Gabapentin enhances the analgesic effect of
morphine in healthy volunteers. Anesth Analg. 91:185–191.
2000.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wang X, Peng J and Wang X: Oxycodone
hydrochloride controlled-release tablet combined with gabapentin
for treatment of advanced cancer with neuropathic pain. Journal of
Modern Oncology. 20:1930–1932. 2012.
|
|
56
|
Gilron I: Gabapentin and pregabalin for
chronic neuropathic and early postsurgical pain: Current evidence
and future directions. Curr Opin Anaesthesiol. 20:456–472.
2007.PubMed/NCBI View Article : Google Scholar
|
